In animal research, increasing plasma adiponectin levels through pharmacological or genetic means has shown to alleviate obesity-induced endothelial dysfunction, hypertension, atherosclerosis, myocardial infarction, and diabetic cardiomyopathy
doi:10.1038/s41591-024-03018-2 Coskun T, Urva S, Roell WC, et al
Acknowledgements SVP kindly acknowledges the financial support for this research project from the National academy of Sciences (NASI), Allahabad, India, special ST welfare program
Animal studies on GLP-1 receptor agonists show fetal harm at doses similar to human therapeutic doses
Conclusion Starting Semaglutide at the correct dose is crucial for a successful weight loss journey